Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
2(66.7%)
N/A
1(33.3%)
3Total
Phase 2(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02684669Phase 2Completed

Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia During a Burn Injury

Role: lead

NCT02976337Phase 2Completed

Effect of High-dose Naloxone Following Third Molar Extraction

Role: lead

NCT05238571Completed

Does Re-surgery Improve Somatosensory Outcomes in Persistent Pain After Groin Hernia Repair

Role: lead

NCT01296334Not ApplicableCompleted

Analgesic and Antihyperalgesic Effects of Morphine and Buprenorphine

Role: lead

All 4 trials loaded